Clinical trials: Breast Neoplasms, completed
Breast Neoplasms, Prostate Cancer
Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer
Taxotere® can induce nails changes like dyschromia, hematoma, lines of Beau-Reil (signing the stop of the epithelial proliferation), abscess, or pain.
- Conditions
- Breast Neoplasms, Prostate Cancer, Nail Diseases
- Trial name
- CRYO1 (NCT00925418)
- Testing
- Frozen Glove
- Where
- France
- Volunteers
- 168 people
- Sponsor
- Institut Paoli-Calmettes
Breast Cancer
99mTc-ADAPT6-based HER2 Imaging in Breast Cancer
The study should evaluate distribution of 99mTc- ADAPT6 in patients with primary HER2-positive and HER2-negative breast cancer. The primary objective are: 1.
- Trial name
- 99mTc-ADAPT6 (NCT03991260)
- Testing
- SPECT
- Where
- Russia
- Volunteers
- 16 people
- Sponsor
- Tomsk National Research Medical Center of the Russian Academy of Sciences
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8
Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint Trial
This trial studies new methods using Tai Chi for the relief of joint pain (arthralgia) caused by an aromatase inhibitor in patients with stage I-III breast cancer.
- Conditions
- Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
- Trial name
- NCT04716920
- Testing
- Tai Chi, FitBit, Support Group Therapy
- Where
- United States
- Volunteers
- 39 people
- Sponsor
- Thomas Jefferson University
ER+ HER2- Advanced Breast Cancer
AZD9496 First Time in Patients Ascending Dose Study
This is a phase 1 open label multicentre study of AZD9496 administered orally in patients with advanced ER+ HER2 negative breast cancer.
- Trial name
- NCT02248090
- Testing
- AZD9496
- Where
- 6 sites in United States, South Korea and 1 more
- Volunteers
- 45 people
- Sponsor
- AstraZeneca
Radiation Dermatitis
Evaluation of the Effect of Nigella Sativa for the Prophylaxis to Radiation Induced Dermatitis in Breast Cancer Patients
Radiation induced dermatitis (RID) is one of the leading adverse events of radiation therapy, and if occurred could alter the course of therapy.
- Trial name
- NCT05693597
- Testing
- Imtenan Oil, Baraka Capsules
- Where
- Egypt
- Volunteers
- 132 people
- Sponsor
- German University in Cairo
Breast Cancer
Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity
This prospective randomized controlled study is conducted to analyze the effect of Goserelin on ovarian function in women with breast cancer in China.
- Trial name
- NCT02518191
- Testing
- GnRHa
- Where
- 2 sites in China
- Volunteers
- 345 people
- Sponsor
- Xiangyun Zong
Breast Cancer, Circulating Tumor Cells (CTCs)
Digoxin Induced Dissolution of CTC Clusters
This single arm therapeutic exploratory study of digoxin in patients with advanced or metastatic breast cancer investigates whether cardiac glycosides are able to disrupt CTC clusters in breast cancer patients.
- Trial name
- NCT03928210
- Testing
- Digoxin
- Where
- 3 sites in Switzerland
- Volunteers
- 58 people
- Sponsor
- University Hospital, Basel, Switzerland
Breast Cancer
Impact of a Rehabilitation Programme for Mothers With Breast Cancer and Their Children
About 1/3 of newly diagnosed breast cancer patients are mothers of children who still live at home. They face additional challenges and stress, their children are also affected by the mother's illness.
- Trial name
- NCT00916825
- Testing
- rehabilitation programme "getting better together"
- Where
- Germany
- Volunteers
- 801 people
- Sponsor
- Philipps University Marburg
Breast Neoplasms
Multimodal Respiratory Physiotherapy in Women Receiving Radiotherapy for Breast Cancer (RESPIRA-BC)
Radiotherapy is an important treatment for breast cancer, but it may affect lung function and physical ability, making everyday activities more difficult.
- Trial name
- RESPIRA-BC (NCT07884968)
- Testing
- Incentive Spirometry (IS) and Positive Expiratory Pressure (PEP) Training, Individualised Exercise Programme (Aerobic and Resistance Training), Patient Education Programme
- Where
- Spain
- Volunteers
- 22 people
- Sponsor
- University of Alcala
Breast Cancer
Promoting a Healthier Lifestyle Among Breast Cancer Survivors
The purpose of this study is to find out if a counseling program the investigators have developed can help breast cancer survivors adopt a healthier lifestyle.
- Trial name
- NCT01419613
- Testing
- Motivational Interviewing, Counseling
- Where
- United States
- Volunteers
- 68 people, healthy volunteers welcome
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
Breast Cancer
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using raloxifene and tamoxifen may fight breast cancer by blocking the uptake of estrogen by the tumor cells.
- Trial name
- NCT00003906
- Testing
- Raloxifene, Tamoxifen
- Where
- 516 sites in United States, Canada and 1 more
- Volunteers
- 19,747 people
- Sponsor
- NSABP Foundation Inc
Breast Cancer, Fatigue
Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer
RATIONALE: Yoga may improve symptoms and quality of life and reduce stress in patients with ovarian cancer or breast cancer and may help them live more comfortably.
- Conditions
- Breast Cancer, Fatigue, Ovarian Cancer, Psychosocial Effects of Cancer and Its Treatment
- Trial name
- NCT00337233
- Testing
- yoga therapy
- Where
- United States
- Volunteers
- 106 people
- Sponsor
- Wake Forest University Health Sciences
Breast Cancer
Mapping Arterial Perforators Within the Breast During Mammoplasty
Breast cancer surgery can often be carried out as part of a breast reduction procedure known as 'therapeutic mammoplasty'. Where a woman has a breast with adequate volume, even larger cancers can be removed in an aesthetically…
- Trial name
- Map-total (NCT06347952)
- Testing
- Use of Acoustic and color imaging doppler during surgery for breast cancer
- Where
- United Kingdom
- Volunteers
- 80 people
- Sponsor
- Royal Marsden NHS Foundation Trust
Metastatic Breast Cancer
Observational Retrospective Study to Assess the Use of Ribociclib in Patients With HR+, HER2- Metastatic Breast Cancer Treated With Chemotherapy
EILEEN was a non-interventional/observational, retrospective, multi-center, real life cohort study conducted in 14 private and academic oncology clinics in Turkey.
- Trial name
- NCT06619704
- Where
- United States
- Volunteers
- 194 people
- Sponsor
- Novartis Pharmaceuticals
Colorectal Cancer (CRC), Endometrial Cancer
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
This is an open-label, multicenter, Phase 1b platform study in subjects with advanced or metastatic solid tumors (Part 1a) and subjects with selected solid tumors (Part 1b and Part 2).
- Conditions
- Colorectal Cancer (CRC), Endometrial Cancer, Melanoma, Head and Neck Cancer
- Trial name
- NCT02646748
- Testing
- Pembrolizumab, itacitinib, INCB050465
- Where
- 17 sites in United States
- Volunteers
- 159 people
- Sponsor
- Incyte Corporation
Health Knowledge, Attitudes, Practice, Alcohol Consumption
Increasing Knowledge of Alcohol as a Risk Factor for Breast Cancer Among Women Attending Breast Screening Services
Alcohol is a major modifiable risk factor for breast cancer in women, yet this is not widely understood by health practitioners or policy makers, let alone the general population.
- Trial name
- Health4Her (NCT04715516)
- Testing
- alcohol brief intervention, lifestyle health promotion
- Where
- Australia
- Volunteers
- 558 people, healthy volunteers welcome
- Sponsor
- Turning Point
Breast Cancer
A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer
This study is designed to determine the efficacy of the biweekly pemetrexed/gemcitabine regimen when given to patients with metastatic breast cancer.
- Trial name
- NCT00191347
- Testing
- pemetrexed, gemcitabine
- Where
- Canada
- Volunteers
- 30 people
- Sponsor
- Eli Lilly and Company
Metastatic Breast Cancer
Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer
Compare the response rate after 6 months of hormone treatment (or a major change in hormone treatment) in metastatic breast cancer, according to the uptake of FES in metastatic lesions taking-up FDG on PET/CT at baseline.
- Trial name
- ESTROTEPREDIC (NCT01627704)
- Testing
- Fluoroestradiol (18F)
- Where
- France
- Volunteers
- 72 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Breast Cancer
Cancer Patient Perspectives During COVID-19
A web-based survey will be emailed to all adult women diagnosed with invasive breast cancer or ductal carcinoma in situ who have been seen as surgical consultations within the last year (06/01/19-06/01/20).
- Trial name
- NCT05062538
- Where
- United States
- Volunteers
- 89 people
- Sponsor
- University of Colorado, Denver
Extensive Stage Small Cell Lung Cancer, Hereditary Paraganglioma
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
RATIONALE: Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as vinorelbine ditartrate, work in different ways to stop the growth of tumor…
- Conditions
- Extensive Stage Small Cell Lung Cancer, Hereditary Paraganglioma, Male Breast Cancer, Malignant Paraganglioma
- Trial name
- NCT01155258
- Testing
- temsirolimus, vinorelbine ditartrate
- Where
- United States
- Volunteers
- 19 people
- Sponsor
- University of Southern California
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.